A detailed history of Susquehanna International Group, LLP transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 115,054 shares of PRME stock, worth $385,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115,054
Previous 105,892 8.65%
Holding current value
$385,430
Previous $544,000 18.2%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.41 - $6.7 $31,242 - $61,385
9,162 Added 8.65%
115,054 $445,000
Q2 2024

Aug 15, 2024

BUY
$4.3 - $8.03 $363,694 - $679,177
84,580 Added 396.87%
105,892 $544,000
Q1 2024

May 07, 2024

SELL
$6.35 - $9.39 $160,483 - $237,313
-25,273 Reduced 54.25%
21,312 $149,000
Q4 2023

Feb 14, 2024

BUY
$5.59 - $9.55 $260,410 - $444,886
46,585 New
46,585 $412,000
Q2 2023

Aug 11, 2023

BUY
$11.41 - $17.05 $139,818 - $208,930
12,254 New
12,254 $179,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $321M
More about PRME
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.